Ornithine and Enoxaparin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ornithine (ornithine) and Enoxaparin sodium (enoxaparin sodium). Common drug interactions include thrombocytopenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ornithine and Enoxaparin sodium. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Ornithine?

Ornithine has active ingredients of ornithine. eHealthMe is studying from 591 Ornithine users. Check the latest studies of Ornithine.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

On Jul, 11, 2026

22 people who take Ornithine and Enoxaparin sodium together, and have interactions are studied.

Ornithine and Enoxaparin sodium drug interactions.

What are the common drug interactions of Ornithine and Enoxaparin Sodium, by gender? *:

female:

Thrombocytopenia (decrease of platelets in blood)
Acidosis (build-up of carbon dioxide in the blood)
Anisocytosis (patient's red blood cells are of unequal size)
Blood bilirubin increased
Blood creatinine increased
Blood pressure decreased
Blood urea increased
Bradycardia (abnormally slow heart action)
Creatinine renal clearance decreased
Drug level above therapeutic

male:

Anaemia (lack of blood)
Pleural effusion (water on the lungs)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Ascites (accumulation of fluid in the abdominal cavity)
Atelectasis (partial or complete collapse of the lung)
Bile duct necrosis
Bile duct stenosis (abnormal narrowing of the common bile duct)
Biliary tract disorder
Blood bilirubin increased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)

What are the common drug interactions of Ornithine and Enoxaparin Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Thrombocytopenia (decrease of platelets in blood)

30-39:

Anuria (failure of the kidneys to produce urine)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Atelectasis (partial or complete collapse of the lung)
Bile duct necrosis
Bile duct stenosis (abnormal narrowing of the common bile duct)
Biliary tract disorder
Blood bilirubin increased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
C-reactive protein increased
Cardiac failure

40-49:

n/a

50-59:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Hyperkalaemia (damage to or disease of the kidney)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Oedema peripheral (superficial swelling)
Pleural effusion (water on the lungs)

60+:

Anaemia (lack of blood)
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
Anisocytosis (patient's red blood cells are of unequal size)
Blood bilirubin increased
Blood creatinine increased
Blood pressure decreased
Blood urea increased
Bradycardia (abnormally slow heart action)
Creatinine renal clearance decreased
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

What are the existing conditions these people have? *

Cardiac Failure: 6 people, 27.27%
Hypokalemia (low potassium): 6 people, 27.27%
Anaemia (lack of blood): 5 people, 22.73%
Constipation: 5 people, 22.73%
Rashes (redness): 4 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 18.18%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 18.18%
High Blood Pressure: 4 people, 18.18%
Type 2 Diabetes: 3 people, 13.64%
Hyperglycemia (high blood sugar): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Ornithine and Enoxaparin sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously